Lipitor Reduces Infection and Respiratory Illnesses

Since the launch of Lipitor back in the late 2002, millions of Americans were in search for their miracle drug to help fight heart disease. Lipitor, whose scientific name is Atorvastatin, is sold by Pfizer. Lipitor is currently used by millions of people throughout the world for various cardiovascular diseases, with the most occurring one being high cholesterol. A recent study conducted by the European Heart Journal, concluded that Lipitor not only helps with cardiovascular disease, but also with infections and respiratory illnesses. These results were quite unexpected by many researchers and doctors worldwide. Some experts have stated that the study clearly had "legacy effects". A legacy effect is defined as an associative effect. If a patient controls his or her intake of sugar or fatty foods, other benefits are seen besides the ones they focus on. In reality, the facts are hard to turn a blind eye to. The group on Lipitor had about a 36% lower mortality rate in deaths from infection and respiratory illnesses. Studies like this, and the past success of Lipitor have motivated Pfizer to try to get an over the counter approval.

This study from the European Heart Journal has the pulse oximetry industry taking it another step forward. Using the fact that this study had a positive legacy effect, they are promoting the use of a pulse oximeter. A pulse oximeter, also known as a pulse ox, is a medical device used to monitor blood oxygen saturation and pulse rate of an individual. Almost 70% of the people using a pulse oximeter use it to monitor his or her oxygen level. By doing so, they are also monitoring their pulse or heart rate. Considering this, a pulse oximeter also has had a legacy effect amongst its users. Patients have become more and more aware of what their heart rates are, and what a good or bad range is. The opposite is also true. Individuals, who use a pulse oximeter mainly for their pulse rate, have become more aware of their oxygen levels.

The pulse oximeter industry is currently working to team up with Pfizer and another un-named source to further conduct a study focusing more on respiratory needs. Just like cardiovascular disease is on the rise in the United States, so are respiratory illnesses. Asthma and COPD are becoming more common among both children and adults. Many experts are concerned and are pushing for more awareness and research.

About the Author

For high quality, low-cost pulse oximeter and oximeter models, visit us at http://www.PulseOximetersPlus.com.